Companies partner to perform trials of antimicrobial topical treatmentJanuary 9, 2019Stonehaven Incubate and antimicrobial protein specialist Lysando have agreed to jointly conduct proof-of-concept trials for new topical treatments based on Artilysin, a new antimicrobial platform technology.
SPONSORED CONTENTSee what precise nutrition can do.Get to the bottom of tough gastrointestinal cases and recommend diets precisely designed to meet your patients' unique needs. + Find out more